These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9262358)
1. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes. Iwatsubo T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Yokoi T; Kamataki T; Sugiyama Y J Pharmacol Exp Ther; 1997 Aug; 282(2):909-19. PubMed ID: 9262358 [TBL] [Abstract][Full Text] [Related]
2. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data. Iwatsubo T; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358 [TBL] [Abstract][Full Text] [Related]
3. Identification of human cytochrome P-450 isoforms involved in metabolism of R(+)- and S(-)-gallopamil: utility of in vitro disappearance rate. Suzuki A; Iida I; Tanaka F; Akimoto M; Fukushima K; Tani M; Ishizaki T; Chiba K Drug Metab Dispos; 1999 Nov; 27(11):1254-9. PubMed ID: 10534309 [TBL] [Abstract][Full Text] [Related]
4. Prediction of in vivo nonlinear first-pass hepatic metabolism of YM796 from in vitro metabolic data. Iwatsubo T; Hisaka A; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 1998 Jul; 286(1):122-7. PubMed ID: 9655850 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue. Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515 [TBL] [Abstract][Full Text] [Related]
6. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Miyazawa M; Shindo M; Shimada T Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812 [TBL] [Abstract][Full Text] [Related]
7. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860 [TBL] [Abstract][Full Text] [Related]
8. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Shimada T; Tsumura F; Yamazaki H Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312 [TBL] [Abstract][Full Text] [Related]
9. Determination of the rate-limiting step in the hepatic elimination of YM796 by isolated rat hepatocytes. Iwatsubo T; Suzuki H; Sugiyama Y Pharm Res; 1999 Jan; 16(1):110-6. PubMed ID: 9950288 [TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol. Usmani KA; Hodgson E; Rose RL Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Stringer RA; Strain-Damerell C; Nicklin P; Houston JB Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847 [TBL] [Abstract][Full Text] [Related]
12. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875 [TBL] [Abstract][Full Text] [Related]
13. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Subrahmanyam V; Renwick AB; Walters DG; Young PJ; Price RJ; Tonelli AP; Lake BG Drug Metab Dispos; 2001 Aug; 29(8):1146-55. PubMed ID: 11454734 [TBL] [Abstract][Full Text] [Related]
14. A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. Kawashiro T; Yamashita K; Zhao XJ; Koyama E; Tani M; Chiba K; Ishizaki T J Pharmacol Exp Ther; 1998 Sep; 286(3):1294-300. PubMed ID: 9732391 [TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
16. In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans. Hirota N; Ito K; Iwatsubo T; Green CE; Tyson CA; Shimada N; Suzuki H; Sugiyama Y Biopharm Drug Dispos; 2001 Mar; 22(2):53-71. PubMed ID: 11745908 [TBL] [Abstract][Full Text] [Related]
17. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165 [TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523 [TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Fang J; McKay G; Song J; Remillrd A; Li X; Midha K Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183 [TBL] [Abstract][Full Text] [Related]
20. Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Lemoine A; Gautier JC; Azoulay D; Kiffel L; Belloc C; Guengerich FP; Maurel P; Beaune P; Leroux JP Mol Pharmacol; 1993 May; 43(5):827-32. PubMed ID: 8502233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]